Elevance Health Inc. (ELV) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | 4.33B | 84M | 1.14B | 2.05B | 1.02B | 706M | 2.68B | 447M | 1.98B | -2.97B | 2.61B | 1.95B |
| Operating CF Growth % | 325.96% | -88.1% | -57.6% | 359.51% | -48.58% | 123.76% | 2.45% | -77.08% | -69.42% | -95.72% | -46.93% | -20.47% |
| Operating CF / Revenue % | 8.63% | 0.17% | 2.24% | 4.13% | 2.08% | 1.55% | 5.93% | 1.02% | 4.65% | -6.97% | 6.1% | 4.47% |
| Net Income | 1.76B | 546M | 1.19B | 1.74B | 2.18B | 413M | 1.01B | 2.3B | 2.25B | 831M | 1.3B | 1.86B |
| Depreciation & Amortization | 354M | 406M | 387M | 380M | 373M | 398M | 329M | 335M | 331M | 424M | 426M | 433M |
| Stock-Based Compensation | 55M | 30M | 84M | 81M | 81M | -29M | 66M | 92M | 62M | 72M | 78M | 78M |
| Deferred Taxes | -274M | -322M | 269M | -52M | -174M | -116M | -224M | -170M | 136M | -241M | 32M | -138M |
| Other Non-Cash Items | 1.38B | -52M | -42M | 119M | 338M | 58M | 256M | -156M | 188M | 299M | 567M | 164M |
| Working Capital Changes | 1.06B | -524M | -750M | -218M | -1.78B | -18M | 1.24B | -1.96B | -988M | -4.36B | 210M | -443M |
| Cash from Investing | -1.64B | 464M | -1.22B | -687M | 103M | -1.64B | -401M | -818M | -2.31B | -1.03B | -687M | -672M |
| Capital Expenditures | -235M | -293M | -360M | -267M | -196M | -322M | -332M | -323M | -279M | -326M | -319M | -350M |
| Acquisitions | 5M | 33M | 1M | 50M | 4M | -3.72B | 0 | 395M | -1.12B | 18M | 81M | -13M |
| Purchase of Investments | -4.74B | -2.76B | -4.16B | -4.14B | -3.96B | -3.28B | -4.67B | -3.93B | -6.1B | 8.1B | -6.69B | -10.21B |
| Sale/Maturity of Investments | 3.65B | 3.24B | 3.42B | 3.86B | 4.57B | 5.48B | 4.47B | 3.19B | 5.43B | -8.82B | 6.37B | 9.97B |
| Other Investing | -323M | 243M | -123M | -189M | -315M | 205M | 130M | -145M | -241M | 3M | -126M | -77M |
| Cash from Financing | -2.52B | 236M | 243M | -308M | -1.91B | 1.41B | -915M | 668M | 32M | -394M | -994M | -1.43B |
| Dividends Paid | -376M | -377M | -381M | -385M | -386M | -373M | -378M | -378M | -379M | -346M | -348M | -350M |
| Share Repurchases | -1.12B | -471M | -876M | -378M | -880M | -1.81B | -60M | -463M | -566M | -928M | -480M | -646M |
| Stock Issued | 37M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debt Issuance (Net) | -1000K | 1000K | 1000K | 1000K | -1000K | 1000K | -1000K | 1000K | 1000K | 1000K | -1000K | -1000K |
| Other Financing | -291M | -507M | 140M | 260M | 176M | -227M | -119M | 172M | 213M | 19M | 122M | 100M |
| Net Change in Cash | 166M | 778M | 153M | 1.06B | -788M | 422M | 1.37B | 271M | -300M | -4.39B | 928M | -151M |
| Exchange Rate Effect | -9M | -6M | -1M | 1M | 1M | -54M | 8M | -26M | 0 | 1M | -4M | 1M |
| Cash at Beginning | 9.49B | 8.71B | 8.56B | 7.5B | 8.29B | 7.87B | 6.5B | 6.23B | 6.53B | 10.92B | 9.99B | 10.14B |
| Cash at End | 9.66B | 9.49B | 8.71B | 8.56B | 7.5B | 8.29B | 7.87B | 6.5B | 6.23B | 6.53B | 10.92B | 9.99B |
| Free Cash Flow | 4.1B | -209M | 775M | 1.79B | 821M | 384M | 2.35B | 124M | 1.7B | -3.3B | 2.29B | 1.6B |
| FCF Growth % | 399.03% | -154.43% | -66.95% | 1341.13% | -51.68% | 111.65% | 2.22% | -92.25% | -72.45% | -81.55% | -50.34% | -25.82% |
| FCF Margin % | 8.16% | -0.42% | 1.53% | 3.59% | 1.68% | 0.85% | 5.19% | 0.28% | 3.99% | -7.73% | 5.35% | 3.66% |
| FCF per Share | 18.59 | -0.94 | 3.43 | 7.91 | 3.61 | 1.66 | 10.06 | 0.53 | 7.25 | -13.98 | 9.7 | 6.73 |